retatrutide reaults Phase 2 vs Phase 3: Wild Results! First Retatrutide phase 3 data,

Key secondary endpoints included non-inferiority of tirzepatide (5 mg) compared to insulin degludec in HbA1c reduction, superiority of all tirzepatide doses over insulin degludec in HbA1c reduction and weight loss, and the proportion of participants achieving an HbA1c level below 7.0% at week 52

Nutrition dietary advice should also encompass optimal eating patterns including providing guidance on maintaining a regular eating schedule, adopting planned portions sizes and ensuring the quality of food intake (Fig

Normal people with diabetes (or obesity) have to take other (diabetes)medication because the Ozempic is out of stock

Oral Market Dominance: despite the competition in injectables, Novo Nordisk retains a stronghold in the oral segment

Glossary of Terms References Jastreboff AM, Kaplan LM, Frias JP, et al

Acknowledgements We want to acknowledge the participants and investigators of the GTEx, eQTLGen, EBI, IEU, GLGC, DIAMANTE, FinnGen, and UK Biobank study